The report "Viral Inactivation Market by Product
(Kits, Reagents, Systems, Services), Application (Stem Cell, Blood, Tissue,
Cell & Gene Therapy), Method (Solvent Detergent, Pasteurization) & End
User (Pharmaceutical and Biotechnology, CROs) - Global Forecast to 2021"The global viral inactivation market was valued at USD 320.5 Million in
2016. This market is expected to grow at a CAGR of 12.3% to reach USD 573.0
Million in 2021.
Browse 72 market
data tables with 70 figures spread through 154 pages and in-depth TOC on "Viral Inactivation Market”
Early buyers
will receive 10% customization on This report.
Viral
inactivation testing is necessary by regulatory authorities for investigational
new drug (IND) submission and is mainly critical in process development for
biologicals including tissue and tissue products, stem cell products, cellular
and gene therapy products, blood and blood products, and vaccine and
therapeutics. The major drivers for the market are rapid growth in
pharmaceutical and biotechnology industries and strong trend of R&D
investments in life sciences industry. Increasing number of new drug launches,
rise in chronic disease burden, and increasing government support for the
pharmaceutical and biotechnology industries will also aid the growth of this
market.
The global viral inactivation market is segmented on the basis of
method, product, application, end user, and geography. By method, the market is
divided into solvent detergent method, pasteurization, and other methods. Other
viral inactivation method includes low pH, microwave heating, irradiation, and
high-energy light. Of these, the solvent detergent method segment accounted for
the largest share of the global viral inactivation market in 2015.
The application segments included in this report are blood &
blood products, cellular & gene therapy products, stem cell products,
tissue & tissue products, and vaccines and therapeutics. Of these the
vaccines and therapeutics application hold the highest share.
By end user, the market is segmented into pharmaceutical and
biotechnology companies, contract research organizations, academic research
institutes, and other end users. Other end user segment primarily includes cell
banks, small cell culture laboratories and consultants, microbiology
laboratories, immunology laboratories, molecular laboratories, animal
facilities, toxicology laboratories, and media/sera manufacturers.
The product segments included in the report are kits and reagents,
services, and viral inactivation systems and accessories.
The Sample Report For This Report@
The geographic segments included in this report are Asia, Europe,
North America, and the Rest of the World (RoW). The North America segment is
further divided into Canada and the U.S. Asia segment is further divided into
China, Japan, India, and Rest of Asia.
Major players in the viral inactivation market include Clean Cells
(France), Charles River Laboratories International, Inc. (U.S.), Danaher
Corporation (U.S.), Merck KGaA (Germany), Parker Hannifin (U.S.), Rad Source
Technologies (U.S.), Sartorius AG (Germany), SGS S.A. (Switzerland), Texcell,
Inc. (France), Viral Inactivated Plasma Systems SA (Switzerland), and WuXi
PharmaTech (Cayman) Inc. (China).
Get The PDF Brochure For This Report@
About MarketsandMarkets™:
MarketsandMarkets™
provides quantified B2B research on 30,000 high growth niche opportunities/threats
which will impact 70% to 80% of worldwide companies’ revenues. Currently
servicing 5000 customers worldwide including 80% of global Fortune 1000
companies as clients. Almost 75,000 top officers across eight industries
worldwide approach MarketsandMarkets™ for their painpoints around revenues
decisions.
Our
850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high
growth markets following the "Growth Engagement Model – GEM". The GEM
aims at proactive collaboration with the clients to identify new opportunities,
identify most important customers, write "Attack, avoid and defend"
strategies, identify sources of incremental revenues for both the company and
its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants
(Positioning top players across leaders, emerging companies, innovators,
strategic players) annually in high growth emerging segments.
MarketsandMarkets™ is determined to benefit more than 10,000 companies this
year for their revenue planning and help them take their
innovations/disruptions early to the market by providing them research ahead of
the curve.
MarketsandMarkets’s
flagship competitive intelligence and market research platform, "RT"
connects over 200,000 markets and entire value chains for deeper understanding
of the unmet insights along with market sizing and forecasts of niche
markets.
Contact:
Mr. Rohan
MarketsandMarkets™
701
Pike Street
Suite
2175, Seattle,
WA
98101, United States
Tel:
1-888-600-6441
No comments:
Post a Comment